Vivani Medical, Inc. VANI
1.24
0.01
0.81%
as of 25 Sep
- Market cap
- $111.0M
- P/E
- 0.0×
Follow VANI
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | — | 25.84 | 8.53 | 13.67 | 19.55 |
P/FCF ratio |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | — | — | (11.82) | (7.60) | (16.21) | (11.10) |
P/B ratio |
— | — | — | — | — | — | 12.00 | 19.06 | 13.81 | 6.99 |
Price to Tangible BV |
— | — | — | — | — | — | 12.00 | 19.06 | 13.81 | 6.99 |
EV/Sales |
— | — | — | — | — | — | 22.56 | 7.88 | 12.68 | 16.82 |
EV/EBITDA |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | — | (2.76) | (1.82) | (4.22) | (2.67) |
EV/FCF |
— | — | — | — | — | — | (2.71) | (1.81) | (4.17) | (2.62) |
Quick Ratio |
2.56 | 3.11 | 3.61 | 6.61 | 1.19 | 0.62 | 1.69 | 0.65 | 1.46 | 1.97 |
Current Ratio |
2.71 | 3.42 | 4.03 | 6.97 | 1.18 | 0.83 | 1.88 | 1.27 | 1.99 | 2.70 |
Net Debt/EBITDA |
0.60 | 0.76 | 0.78 | 2.12 | 0.15 | 0.07 | 0.33 | 0.13 | 0.28 | 0.33 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.87% | 3.39% | 49.33% | 1.43% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.02 | 0.08 | (3.27) | 0.03 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.55 | 0.51 | 0.18 |
Operating CF/Net income |
0.91 | 0.89 | 0.92 | 1.35 | 0.86 | 1.13 | 0.82 | 0.85 | 0.84 | 0.76 |
Capex/Depreciation |
(2.77) | (1.39) | (2.48) | (0.89) | (1.66) | 0.41 | (1.24) | (0.37) | (0.58) | (1.13) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (159.62%) | (122.42%) | (78.85%) | (59.39%) | (1,424.76%) | (450.70%) | (648.56%) | (640.05%) | (299.70%) | (211.26%) | |
| (65.74%) | (53.77%) | (52.93%) | (49.09%) | (257.70%) | (141.32%) | (246.27%) | (278.76%) | (182.17%) | (147.28%) | |
ROIC |
0.00% | 0.00% | (15,750.58%) | (7,099.26%) | (1,764.17%) | 0.00% | 0.00% | 0.00% | (41,582.85%) | (7,603.02%) |
Return on Tangible Assets |
(187.72%) | (145.43%) | (134.53%) | (33.16%) | (820.89%) | 2,159.65% | (461.87%) | (1,151.76%) | (363.31%) | (298.67%) |
Average Days of Receivables |
0.00 | 0.00 | — | — | 0.00 | — | 49.15 | 26.68 | 83.92 | 25.10 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 388.96% | 145.08% | 99.11% | 134.18% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 552.86% | 386.14% | 295.87% | 546.35% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 86.56% | 52.04% | 47.51% | 84.49% |
Graham Net Nets |
— | — | — | — | — | — | 0.04 | 0.03 | 0.06 | 0.12 |
Graham Number |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | — | (39.42%) | (59.84%) | (26.37%) | (42.14%) |
Free Cash Flow Yield |
— | — | — | — | — | — | (32.21%) | (50.98%) | (22.25%) | (32.81%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.69 | 2.49 | 3.53 | 2.42 |
Operating CF per Share |
(0.39) | (0.38) | (0.47) | (0.49) | (0.33) | (2.45) | (5.64) | (10.78) | (10.61) | (15.21) |
Capex per Share |
(0.02) | (0.01) | (0.02) | (0.01) | (0.02) | 0.01 | (0.10) | (0.06) | (0.12) | (0.30) |
Free Cash Flow per Share |
(0.41) | (0.39) | (0.48) | (0.50) | (0.35) | (2.44) | (5.74) | (10.84) | (10.73) | (15.51) |
Cash per Share |
0.26 | 0.33 | 0.41 | 1.18 | 0.07 | 0.46 | 2.31 | 1.62 | 3.47 | 6.60 |
Shareholders Equity per Share |
0.25 | 0.32 | 0.41 | 1.16 | 0.07 | (0.10) | 1.48 | 1.12 | 3.49 | 6.77 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.25 | 0.32 | 0.41 | 1.16 | 0.07 | (0.10) | 1.48 | 1.12 | 3.49 | 6.77 |
Free Cash Flow |
(25.49) | (21.34) | (24.59) | (19.12) | (11.52) | (16.75) | (28.12) | (29.97) | (24.21) | (25.56) |
Working Capital |
11.30 | 14.46 | 17.34 | 40.71 | 0.38 | (0.86) | 6.15 | 2.02 | 6.55 | 9.62 |
Capital Expenditures |
(1.17) | (0.56) | (0.89) | (0.34) | (0.57) | 0.07 | (0.49) | (0.16) | (0.26) | (0.49) |
Net Current Asset Value |
(5.76) | (3.51) | (1.97) | 40.71 | (0.52) | (0.86) | 3.79 | 2.02 | 6.55 | 9.62 |
EV/EBIT |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.02 | 0.03 | 0.12 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (994.14%) | (508.90%) | (358.06%) | (832.60%) |
Price to Operating Income |
— | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.15 | 0.24 | 0.21 | 0.32 | 0.29 | 0.94 | 0.35 | 0.42 | 0.35 | 0.29 |
Cash ROIC |
(85.10%) | (62.51%) | (61.40%) | (22.10%) | (251.12%) | (361.23%) | (152.61%) | (408.14%) | (160.59%) | (120.60%) |
Accounts Receivable Turnover |
0.00 | 0.00 | — | — | 0.00 | — | 7.05 | 5.91 | 7.57 | 4.49 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.21 | (0.63) | 1.79 | 4.75 | 5.36 | 10.80 |
Inventory Turnover |
— | — | — | — | 0.00 | (0.64) | 1.01 | 1.64 | 1.67 | 1.73 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 1,298.29 | (354.78) | 185.38 | 97.45 | 53.64 | 41.88 |
Days of Inventory on Hand |
— | — | — | — | 0.00 | (386.17) | 174.53 | 242.69 | 192.59 | 123.74 |
Average Receivables |
0.45 | 0.28 | — | — | 0.38 | — | 0.48 | 1.17 | 1.05 | 0.89 |
Average Payables |
0.92 | 0.68 | 0.86 | 0.73 | 0.38 | 0.79 | 1.20 | 1.03 | 0.95 | 0.93 |
Average Inventory |
— | — | — | — | — | 0.78 | 2.14 | 2.98 | 3.06 | 5.81 |
Average Assets |
40.48 | 43.68 | 48.46 | 28.29 | 4.96 | 10.53 | 13.64 | 12.59 | 15.65 | 22.53 |
Average Common Equity |
16.67 | 19.19 | 32.53 | 23.39 | 0.90 | 3.30 | 5.18 | 5.48 | 9.52 | 15.71 |
Columns are period end dates